Expression of concern: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy
© Marincola; licensee BioMed Central Ltd. 2014
Received: 9 October 2014
Accepted: 10 October 2014
Published: 4 November 2014
After publication of this article , it was brought to the journal's attention that there were several potential concerns regarding the reliability of the data presented within it.
There is uncertainty regarding the timing of the images in figures 5 and 7.
Despite extensive efforts to obtain an independent investigation, we have been unable to verify these claims or come to a definitive conclusion regarding the reliability of the data. Readers are therefore urged to take caution when interpreting the content of this article.
Readers are alerted that an erratum has also been published regarding the authorship of this article .
- Wu AY, Morrow DM: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy. J Transl Med. 2013, 11: 136-10.1186/1479-5876-11-136.PubMed CentralView ArticlePubMedGoogle Scholar
- Marincola F: Erratum: Autologous fat transfer with in-situ mediation (AIM): a novel and compliant method of adult mesenchymal stem cell therapy. J Transl Med. 2013, 12: 269-10.1186/s12967-014-0269-z.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.